tiprankstipranks
Cormedix (CRMD)
NASDAQ:CRMD
Holding CRMD?
Track your performance easily

Cormedix (CRMD) Technical Analysis

1,222 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Cormedix’s (CRMD) Moving Averages Convergence Divergence (MACD) indicator is 0.26, suggesting Cormedix is a Buy.
Cormedix’s (CRMD) 20-Day exponential moving average is 10.87, while Cormedix’s (CRMD) share price is $10.48, making it a Sell.
Cormedix’s (CRMD) 50-Day exponential moving average is 9.77, while Cormedix’s (CRMD) share price is $10.48, making it a Buy.

Cormedix (CRMD) Pivot Points

Nov 21, 2024, 04:27 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.11
10.32
10.69
10.90
11.28
11.49
11.86
Fibonacci
10.32
10.54
10.68
10.90
11.12
11.26
11.49
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cormedix (CRMD) Moving Averages

Nov 21, 2024, 04:27 PM
Period
Simple
Exponential
MA5
10.81Sell
10.90Sell
MA10
11.13Sell
10.96Sell
MA20
11.18Sell
10.87Sell
MA50
9.80Buy
9.77Buy
MA100
7.35Buy
8.23Buy
MA200
5.94Buy
6.57Buy
Cormedix’s (CRMD) 10-Day exponential moving average is 10.96, while Cormedix’s (CRMD) share price is $10.48, making it a Sell.
Cormedix’s (CRMD) 100-Day exponential moving average is 8.23, while Cormedix’s (CRMD) share price is $10.48, making it a Buy.
Cormedix’s (CRMD) stock price is $10.48 and Cormedix’s (CRMD) 50-day simple moving average is 9.80, creating a Buy signal.
Cormedix’s (CRMD) stock price is $10.48 and Cormedix’s (CRMD) 100-day simple moving average is 7.35, creating a Buy signal.
Cormedix’s (CRMD) stock price is $10.48 and Cormedix’s (CRMD) 200-day simple moving average is 5.94, creating a Buy signal.

Cormedix (CRMD) Technical Indicators

Nov 21, 2024, 04:27 PM
Name
Value
Implied Action
RSI (14)
50.62
Neutral
STOCH (9,6)
35.48
Neutral
STOCHRSI (14)
50.22
Neutral
MACD (12,26)
0.26
Buy
ADX (14)
27.42
Neutral
Williams %R
-55.33
Buy
CCI (14)
-20.59
Neutral
ATR (14)
0.76
-
Ultimate Oscillator
43.33
Neutral
ROC
6.76
Buy
Cormedix’s (CRMD) Relative Strength Index (RSI) is 50.62, creating a Neutral signal.
Cormedix’s (CRMD) Trend Strength Indicator (ADX) is 27.42, creating a Neutral signal.
Cormedix’s (CRMD) Commodity Channel Index (CCI) is -20.59, creating a Neutral signal.
Cormedix’s (CRMD) Price Rate of Change (ROC) is 6.76, creating a Buy signal.

FAQ

Is CRMD a Buy, Hold, or Sell?
Based on CRMD’s technical indicators, CRMD is a Buy.
    What is CRMD’s RSI (14)?
    CRMD’s RSI (14) is 50.62, which suggests CRMD is a Neutral.
      What is CRMD’s MACD?
      CRMD’s MACD is 0.26, which suggests CRMD is a Buy.
        What is CRMD’s 5-day moving average?
        CRMD’s 5-day moving average is 10.81, which suggests CRMD is a Sell.
          What is CRMD’s 20-day moving average?
          CRMD 20-day moving average is 11.18, which suggests CRMD is a Sell.
            What is CRMD’s 50-day moving average?
            CRMD’s 50-day moving average is 9.80, which suggests CRMD is a Buy.
              What is CRMD’s 200-day moving average?
              CRMD’s 200-day moving average is 5.94, which suggests CRMD is a Buy.
                What is CRMD’s Williams % R (14)?
                CRMD’s Williams % R (14) is -55.33, which suggests CRMD is a Buy.
                  What is CRMD’s CCI (14)?
                  CRMD’s CCI (14) is -20.59, which suggests CRMD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis